Federal Contractor Profile
Medicines Company, The
Federal contracting record: $98M obligated across 3 awards from 2 agencies, FY 2016–2026.
Company Profile
UEI (Unique Entity Identifier)
ZCK2MH2VMA26
CAGE Code
37CG9
Parent Organization
Medicines Company, The
Address
8 SYLVAN WY, PARSIPPANY, NJ, 070544409
First Federal Award
Dec 28, 2015
Most Recent Award
Feb 20, 2026
Federal Sales Analytics
Toggle between trend, agency drilldown, and treemap. Use the period selector to focus the time window.
Hover any bar for YoY change + award count. Current fiscal year shown at reduced opacity (partial year).
Top Federal Agencies
- $98M
Department of Health and Human Services
100.0% of total obligations
- $0
Department of Veterans Affairs
0.0% of total obligations
Top NAICS Activity
- $98M
541711
RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY
1 awards
- $0
325412
PHARMACEUTICAL PREPARATION MANUFACTURING
2 awards
Recent Federal Awards
| Date | Agency | NAICS | Description | Amount |
|---|---|---|---|---|
| Apr 22, 2024 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | 541711 | THE MEDICINE COMPANY - ADVANCE THE DEVELOPMENT OF A PORTFOLIO OF ANTI-INFECTIVE PROGRAMS. IGF::OT::IGF | $10M |
| Sep 29, 2022 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | 541711 | THE MEDICINE COMPANY - ADVANCE THE DEVELOPMENT OF A PORTFOLIO OF ANTI-INFECTIVE PROGRAMS. IGF::OT::IGF | $6.1M |
| Mar 31, 2021 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | 541711 | THE MEDICINE COMPANY - ADVANCE THE DEVELOPMENT OF A PORTFOLIO OF ANTI-INFECTIVE PROGRAMS. IGF::OT::IGF | $15M |
| Apr 22, 2020 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | 541711 | THE MEDICINE COMPANY - ADVANCE THE DEVELOPMENT OF A PORTFOLIO OF ANTI-INFECTIVE PROGRAMS. IGF::OT::IGF | $15M |
| Aug 13, 2019 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | 541711 | THE MEDICINE COMPANY - ADVANCE THE DEVELOPMENT OF A PORTFOLIO OF ANTI-INFECTIVE PROGRAMS. IGF::OT::IGF | $20M |
| Sep 15, 2016 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | 541711 | THE MEDICINE COMPANY - ADVANCE THE DEVELOPMENT OF A PORTFOLIO OF ANTI-INFECTIVE PROGRAMS. IGF::OT::IGF | $32M |
Related Contractors
Other companies active in NAICS 541711 — RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY.
Track Medicines Company, The Recompetes Before They Post
Mindy monitors Medicines Company, The's active contracts and alerts you 12 months before they expire — so you can position to compete on recompete.
Get Free Recompete Alerts